APP and early-onset autosomal dominant Alzheimer disease: Most APP-related studies in DS have focused on adult neurological effects rather than developmental effects of APP dosage imbalance, because elevated APP expression contributes to Alzheimer's disease neuropathology and accumulation of Aβ deposits in individuals with DS (Wiseman et al., 2015).